117 related articles for article (PubMed ID: 18691848)
1. Blockade of an angiotensin type I receptor enhances effects of radiation on tumor growth and tumor-associated angiogenesis by reducing vascular endothelial growth factor expression.
Ohnuma Y; Toda M; Fujita M; Hosono K; Suzuki T; Ogawa Y; Amano H; Kitasato H; Hayakawa K; Majima M
Biomed Pharmacother; 2009 Feb; 63(2):136-45. PubMed ID: 18691848
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth.
Fujita M; Hayashi I; Yamashina S; Fukamizu A; Itoman M; Majima M
Carcinogenesis; 2005 Feb; 26(2):271-9. PubMed ID: 15637093
[TBL] [Abstract][Full Text] [Related]
3. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis.
Fujita M; Hayashi I; Yamashina S; Itoman M; Majima M
Biochem Biophys Res Commun; 2002 Jun; 294(2):441-7. PubMed ID: 12051731
[TBL] [Abstract][Full Text] [Related]
4. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination.
Suganuma T; Ino K; Shibata K; Kajiyama H; Nagasaka T; Mizutani S; Kikkawa F
Clin Cancer Res; 2005 Apr; 11(7):2686-94. PubMed ID: 15814650
[TBL] [Abstract][Full Text] [Related]
5. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
6. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.
Gorski DH; Beckett MA; Jaskowiak NT; Calvin DP; Mauceri HJ; Salloum RM; Seetharam S; Koons A; Hari DM; Kufe DW; Weichselbaum RR
Cancer Res; 1999 Jul; 59(14):3374-8. PubMed ID: 10416597
[TBL] [Abstract][Full Text] [Related]
7. Candesartan, an angiotensin II type 1 receptor antagonist, inhibits pathological retinal neovascularization by downregulating VEGF receptor-2 expression.
Nakamura S; Tsuruma K; Shimazawa M; Hara H
Eur J Pharmacol; 2012 Jun; 685(1-3):8-14. PubMed ID: 22543084
[TBL] [Abstract][Full Text] [Related]
8. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth.
Egami K; Murohara T; Shimada T; Sasaki K; Shintani S; Sugaya T; Ishii M; Akagi T; Ikeda H; Matsuishi T; Imaizumi T
J Clin Invest; 2003 Jul; 112(1):67-75. PubMed ID: 12840060
[TBL] [Abstract][Full Text] [Related]
9. Glomerular repair retardation via blocking of angiotensin II type 1a receptor pathway in a mouse glomerulonephritis model.
Hayashi W; Obata Y; Nishino T; Abe S; Io K; Furusu A; Abe K; Miyazaki M; Sugaya T; Koji T; Kohno S
Nephron Exp Nephrol; 2012; 122(1-2):13-22. PubMed ID: 23446008
[TBL] [Abstract][Full Text] [Related]
10. Antagonism of the renin-angiotensin system can counteract cardiac angiogenic vascular endothelial growth factor gene therapy and myocardial angiogenesis in the normal heart.
Siddiqui AJ; Mansson-Broberg A; Gustafsson T; Grinnemo KH; Dellgren G; Hao X; Fischer H; Sylvén C
Am J Hypertens; 2005 Oct; 18(10):1347-52. PubMed ID: 16202860
[TBL] [Abstract][Full Text] [Related]
11. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
12. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancer.
Kosugi M; Miyajima A; Kikuchi E; Horiguchi Y; Murai M
Clin Cancer Res; 2006 May; 12(9):2888-93. PubMed ID: 16675585
[TBL] [Abstract][Full Text] [Related]
14. Negative regulation of VEGF-induced vascular leakage by blockade of angiotensin II type 1 receptor.
Sano H; Hosokawa K; Kidoya H; Takakura N
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2673-80. PubMed ID: 16973968
[TBL] [Abstract][Full Text] [Related]
15. Roles for host and tumor angiotensin II type 1 receptor in tumor growth and tumor-associated angiogenesis.
Imai N; Hashimoto T; Kihara M; Yoshida S; Kawana I; Yazawa T; Kitamura H; Umemura S
Lab Invest; 2007 Feb; 87(2):189-98. PubMed ID: 17318197
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type 1 receptor antagonist enhances cis-dichlorodiammineplatinum-induced cytotoxicity in mouse xenograft model of bladder cancer.
Kosugi M; Miyajima A; Kikuchi E; Kosaka T; Horiguchi Y; Murai M; Oya M
Urology; 2009 Mar; 73(3):655-60. PubMed ID: 19167032
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer.
Chen X; Meng Q; Zhao Y; Liu M; Li D; Yang Y; Sun L; Sui G; Cai L; Dong X
Cancer Lett; 2013 Jan; 328(2):318-24. PubMed ID: 23092556
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type 1 receptor antagonist suppress angiogenesis and growth of gastric cancer xenografts.
Huang W; Wu YL; Zhong J; Jiang FX; Tian XL; Yu LF
Dig Dis Sci; 2008 May; 53(5):1206-10. PubMed ID: 17934850
[TBL] [Abstract][Full Text] [Related]
19. Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor.
Nagai N; Noda K; Urano T; Kubota Y; Shinoda H; Koto T; Shinoda K; Inoue M; Shiomi T; Ikeda E; Tsubota K; Suda T; Oike Y; Ishida S
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1078-84. PubMed ID: 15728568
[TBL] [Abstract][Full Text] [Related]
20. [Effect of irradiation on matrix metalloproteinases, vascular endothelial growth factor and microvessel density of mice bearing Lewis lung cancer].
Ai P; Ren ZG; Wang X; Wang SC; Li P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):632-5. PubMed ID: 19764560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
